Status:

COMPLETED

Dynamic Assessment and Referral System - Evaluation

Lead Sponsor:

University of Massachusetts, Worcester

Conditions:

Smoking

Alcohol Abuse

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The investigators study will use a randomized controlled design. Eligible and consenting participants will be randomly assigned to one of two conditions: (1) DARSSA Intervention condition, or (2) Mini...

Detailed Description

Screening process. All patients who verbally consent to being screened by the RA will undergo a computer assisted screening for substance abuse (Rapid Screener) administered by the research assistant....

Eligibility Criteria

Inclusion

  • \- Age 18 years or older and receiving treatment in the ED

Exclusion

  • sustained altered mental status (e.g., psychosis, delirium, disorientation, unresponsive)
  • hostile or agitated behavior
  • sexual assault victims
  • trauma patients who are on backboards or who must remain supine
  • severe illness that would preclude conversation or interface with a computer (e.g., intubation, persistent vomiting, severe pain)
  • or factors precluding follow-up, like transient residence or lack of a telephone.

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

758 Patients enrolled

Trial Details

Trial ID

NCT01153373

Start Date

June 1 2010

End Date

April 1 2015

Last Update

April 9 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UMass Memorial Medical Center - university campus

Worcester, Massachusetts, United States, 01655